More than two-thirds of adolescents who suffer from depression could see long-term benefits from receiving one of three psychological treatments – of which only one is currently recommended on the NHS – according to research published today in The Lancet Psychiatry.
Joe Herbert, Emeritus Professor of Neuroscience, explores what we mean by 'gender identity' and asks whether we should insist on an equal gender distribution across occupations and activities.
A BLUEPRINT for blood cells: Cambridge researchers play leading role in major release of epigenetic studies17 Nov 2016
Cambridge researchers have played a leading role in several studies released today looking at how variation in and potentially heritable changes to our DNA, known as epigenetic modifications, affect blood and immune cells, and how this can lead to disease.
Healthcare is a complex beast and too often problems arise that can put patients’ health – and in some cases, lives – at risk. A collaboration between the Cambridge Centre for Health Services Research and the Department of Engineering hopes to get to the bottom of what’s going wrong – and to offer new ways of solving the problems.
A large-scale genetic study has provided strong evidence that the development of insulin resistance – a risk factor for type 2 diabetes and heart attacks and one of the key adverse consequences of obesity – results from the failure to safely store excess fat in the body.
A new suite of laboratories aimed at improving outcomes for patients with brain injuries and brain tumours opens today at the University of Cambridge.
A multi-drug resistant infection that can cause life-threatening illness in people with cystic fibrosis (CF) and can spread from patient to patient has spread globally and is becoming increasingly virulent, according to new research published today in the journal Science.
A weight loss condition that affects patients with cancer has provided clues as to why cancer immunotherapy – a new approach to treating cancer by boosting a patient’s immune system – may fail in a substantial number of patients.
An ambitious seminar series began last week with a discussion of a remarkable documentary. Filmed in a pioneering hospice, The Time to Die addresses a subject that remains taboo for many. Joining the conversation are health professionals, medical students and members of the public, as well as those interested in film and ethics. The series continues on 9 November 2016.
If you see an injured person by the side of the road, would you stop and help them, or are you more likely to walk on by? What motivates people to do good in such a situation?